ICER (USD/QALY) | Percent coverage of screening (with EoS approach) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Percent coverage of HPV vaccine (not taking into account EoS approach) | Â | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90 | 100 |
10 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
20 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
30 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
40 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
50 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
60 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
70 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
80 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
90 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b | |
100 | − 30a | 120b | 280b | 440b | 600b | 770b | 950b | 1120b | 1300b | 1480b |